Value Lab

Prove value before you scale it.

Value Lab is BUSAC’s system for converting technology opportunities into proven enterprise value: which interventions deserve capital, and which don’t. From quantified hypothesis to production-grade deployment. Scale only what the evidence supports.

We form a quantified view of where value is likely to exist. Then we engineer the evidence required to act on it.

Identify Quantify Engineer Deploy Prove Scale Decision Scale Modify Stop

PRODUCTION ENGINEERING FROM THE START · MEASURABLE VALUE BY DESIGN

The Problem

Technology opportunity is abundant. Proven value is scarce.

Every portfolio has more possible technology interventions than it can pursue. AI. Automation. Pricing. Procurement. Working capital. Sales. Operations. The challenge is no longer access to technology. It is knowing where technology can create meaningful enterprise value, and having the engineering and evidence to turn that opportunity into reality.

Value Lab creates that path. We quantify the economics before significant capital is committed, engineer the intervention into production, measure the resulting operational and financial change, and scale only where the evidence supports it. Not technology adoption. Technology value creation.

How It Works

Six stages. One discipline. Every intervention, every time.

We lock the baseline before we build, and use the strongest practical evidence available to separate real impact from noise. The method is chosen to fit the intervention; the standard never changes.

ILLUSTRATIVE WORKED EXAMPLE: a pricing / discount-leakage hypothesis. Not a published client result.

Stage 01

Identify

Value lever
Pricing / discount leakage
Mechanism
Guided discount authority
Risk
Conversion, churn
Hypothesis
Formed, falsifiable
Stage 02

Quantify

Baseline
Locked, never restated
Leakage
3.8% · €3.4m / yr
Addressable
€2.7–3.6m
Confidence
Interval, stated
Stage 03

Engineer

Build
Pricing engine + approvals
Population
1 region · 12 reps
Scope
2 product categories
Duration
8 weeks
Stage 04

Deploy

Integration
Into real workflows
Controls
Human-in-the-loop
Reliability
Monitored, fail-safe
Tested
Against the locked baseline
Stage 05

Prove

Leakage
4.2% → 2.8%
Side effects
Checked, none material
Observed
€610k ann.
Attributable
€480k ann.
Stage 06

Scale

Decision
Scale: full population
Basis
V4 verified · €480k ann.
Payback
3.3 months on €130k
Next
Adjacent hypothesis

The Value Lab Taxonomy

Not all “value” is equal. We name the difference.

Potential value is not created value. A modelled €4m opportunity is not €4m of actual EBITDA. Value Lab classifies every economic claim by its evidence maturity, and never collapses the levels into one number.

V1 · Potential

Value is hypothesized

There is reason to believe an opportunity exists. It has not yet been quantified or observed.

V2 · Modelled

Value is quantified

The economics are estimated from available data, explicit assumptions and a model. A defensible estimate, not a result.

V3 · Observed

Value is measured

The intervention is deployed or tested, and measurable operational or financial change is observed against a locked baseline.

V4 · Verified

Value is attributed

The value is attributed to the intervention with the strongest feasible evidence design, net of side effects. A number you can defend in front of an IC, an LP or a buyer.

€3m of V1 ≠ €3m of V4. Capital scales on V3–V4. Never on V1.

The Artifact

Every intervention ends in a Value Evidence Record.

Not a PowerPoint. A standardised, auditable record of what was hypothesised, what was measured, what it cost and what was decided. The same format, every time.

  • Identical structure across every intervention, company and fund.
  • Locked baselines and defensible attribution, from diligence through exit.
  • Each record joins a growing evidence library that makes the next decision better.
Value Evidence Record VER-018 · Illustrative
Hypothesis
Discount leakage, guided authority
Baseline
Locked · never restated
Tested
8 weeks · bounded deployment
Verified value
€480k ann. · V4
Cost / payback
€130k · 3.3 months
Decision
Scale: full population

Use Cases · Where We Start

Five value levers where outcomes are measurable, attributable and fast.

We deliberately start where enterprise-value attribution is strongest, not with vague “AI assistant” programmes whose impact can never be isolated. The lever library expands as the evidence base does.

01

Pricing

Discount leakage, corridors, realization.

02

Working Capital

DSO, collections, cash conversion.

03

Procurement

Spend analytics, compliance, terms.

04

Sales

Conversion, coverage, pipeline quality.

05

Finance Ops

Close, forecasting, process cost.

“Before we allocate technology capital across the portfolio, we run it through the Lab.”
The standard Value Lab is built to enable

Who It’s For

Built for allocators who are accountable for outcomes, not activity.

For Private Equity

Know what works before you scale capital across the portfolio.

Turn technology value creation from a bet per company into a repeatable, evidence-backed playbook, with learning that compounds across the fund and stands up at exit.

For Principal Investors

Underwrite technology theses with measured evidence, not vendor decks.

Value Lab prices technology risk the way you price any position: a small commitment buys information, and evidence sizes the next one.

For Portfolio CEOs & CFOs

Test the intervention before it disrupts the organisation.

Bounded pilots, locked baselines, and a stop option that protects the business as much as the budget.

The Compounding Effect

After the proof: one intervention rarely travels alone.

A proven intervention exposes the next bottleneck in the same company. A verified pattern raises the question of where else in the portfolio it applies. Every intervention is recorded the same way: the problem, what was built, what it cost, what it created and how confidently that value could be attributed. BUSAC does not reset to zero after an engagement. What one company proves, the next one starts from. Most relationships begin with one company and one hypothesis. The strongest end up portfolio-wide.

Each record is structured the same way, so evidence compounds across interventions, companies and funds. What it captures, and how it is scored, stays inside BUSAC.

Faster

Proven interventions are codified

The second deployment starts ahead of the first. The tenth starts ahead of the ninth.

Cheaper

Engineering is reused, not rebuilt

Reusable components lower the cost of finding out whether the next opportunity is real.

Sharper

Selection improves with evidence

Knowing what worked, where and at what cost makes the next allocation decision better than the last.

How Engagements Work

Staged commitment. Evidence unlocks the next cheque.

Value Lab is structured the way you would want any investment structured: small capital buys information, information de-risks larger capital.

Stage 1

Opportunity

Economic hypothesis, locked baseline and a quantified opportunity for one value lever. You learn whether the prize justifies building.

Stage 2

Build & Test

We engineer the real intervention and run it in a bounded slice of the business against the locked baseline, measuring economic impact and side effects.

Stage 3

Scale

Production-grade deployment of what the evidence supports: full population, integrated, monitored, governed. Only what works gets scaled.

Ongoing

Portfolio Value Lab

Value Lab as standing capability across the portfolio: a shared evidence library, intervention pipeline and benchmarks that compound fund-wide.

The First Engagement

One hypothesis. One bounded engagement. One decision.

You bring one place where you believe value is hiding: a lever, a company, a bottleneck. It starts smaller than you expect: one Opportunity stage returns the quantified opportunity on a locked baseline, the intervention design, the evidence plan and a go/no-go, before anything is built. From there, we engineer the intervention, deploy it in a bounded part of the business and measure what it creates. You receive a working intervention in production scope, a Value Evidence Record, and a clear recommendation: Scale, Modify or Stop.

You bring

One value hypothesis

A value lever (pricing, DSO, spend…), your operating data, and a bounded test population.

e.g. “We are leaking margin through discretionary discounting.”

Value Lab

We build and measure

01
Lock the baseline, never restated
02
Quantify the addressable opportunity
03
Build the real intervention software
04
Run it in a bounded slice of the business
05
Measure € impact, side effects, attribution

Production engineering, not slides. Bounded scope, bounded risk.

You get

A Value Evidence Record

Verified € impact vs control. Cost, payback, confidence. Deployed working software.

Scale Modify Stop

Evidence you can defend in front of an IC, an LP or a buyer.

OneHypothesis is all it takes to start
WeeksFrom hypothesis to evidence, not quarters
V1 → V4Potential to verified value

A lab that sometimes says “don’t scale”. That is the point.

How It Fits

One firm. One system. One standard.

BUSAC is the firm.

Value Lab is the system that converts technology opportunities into proven enterprise value.

The Value Evidence Record is the artifact every intervention produces.

V1–V4 is the standard every claim is measured against.

The evidence base is the asset that compounds across companies and funds.

Start a Value Lab

Where is unproven capital about to be scaled in your portfolio?

Bring us one value hypothesis. One Opportunity stage tells you whether the prize is real, what it would cost to prove, and how we’d prove it. Weeks, not quarters.

VALUE LAB · LAUNCHING WITH SELECTED PARTNERS.

Let’s Talk